Herbal dipeptidyl peptidase-4 inhibitors for Alzheimer's disease - Kosaraju, Jayasankar;Basavan, Duraiswamy
36,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
18 °P sammeln
  • Broschiertes Buch

A growing body of evidence shows that pharmacological agents used for the treatment of type-2-diabetes such as dipeptidyl peptidase-4 inhibitors have become valuable candidates as disease modifying agents in the treatment of Alzheimer's disease. This book deals with a study investigates the neuroprotective roles of Pterocarpus marsupium and Eugenia jambolana as dipeptidyl peptidase-4 inhibitors in streptozotocin induced Alzheimer's disease. Our finding suggests that Pterocarpus marsupium and Eugenia jambolana are the potential cognitive enhancers against streptozotocin induced Alzheimer's…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
A growing body of evidence shows that pharmacological agents used for the treatment of type-2-diabetes such as dipeptidyl peptidase-4 inhibitors have become valuable candidates as disease modifying agents in the treatment of Alzheimer's disease. This book deals with a study investigates the neuroprotective roles of Pterocarpus marsupium and Eugenia jambolana as dipeptidyl peptidase-4 inhibitors in streptozotocin induced Alzheimer's disease. Our finding suggests that Pterocarpus marsupium and Eugenia jambolana are the potential cognitive enhancers against streptozotocin induced Alzheimer's disease by dipeptidyl peptidase-4 inhibitory action and their neuroprotective action attributed through increase in active glucagon-like peptide-1 levels.
Autorenporträt
Dr. Kosaraju obtained his PhD degree in 2014 from JSS College of Pharmacy, Ooty, India (JSS University). He has developed expertise in the areas of behavioral assessment tests, intracerebroventricular injection in preclinical species. Dr. Kosaraju has an excellent academic record, research experience and is well versed with modern technologies.